RE:RE:RE:RE:RE:RE:RE:Phase 2 Thanks for your response. But it would seem that the 6 extra months of data is worth less than the first three or six. In fact I would go so far as to say that the phase 2 trial should be considered a success or failure at 6 months. If a patient has a simple 2 hour procedure with little to no side effects and cancer is shown to be removed at 3 months and better yet 6 months - is that not enough data for the FDA/HC to see that it works? That its safe? And that it should be immediately approved. I believe that wasting 6 months and lives of many that could treated and saved (thousands?) seems an exercise in the realm insanity. Unless at 6 months they fast track and approve the therapy and keep the trial open only to gather data.